Cite
HARVARD Citation
Salati, M. et al. (n.d.). 770PA novel immune-inflammatory score to predict survival in patients (pts) with advanced biliary tract cancer (ABTC) receiving first-line chemotherapy (1-line cht). Annals of oncology. p. . [Online].